You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 26 No. 2, August 1941 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

GONORRHEAL OPHTHALMIA

TREATMENT WITH A SULFANILAMIDE DERIVATIVE AND INJECTIONS OF MILK

OTIS S. LEE, Jr., M.D.; FRANCIS K. LUM, M.D.

Arch Ophthal. 1941;26(2):268-275.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Before the advent of sulfanilamide and its derivatives into the field of ocular therapy, patients with gonorrheal ophthalmia in St. Luke's Hospital No. 2 were treated by copious and frequent irrigations of the conjunctival sacs, local applications of antiseptics and injection of nonspecific foreign proteins. Of the last-mentioned substances, milk was subjected to the most thorough trial. With its use in the treatment of gonorrheal ophthalmia, formerly cured in from one to two months with local therapy alone, only about two weeks is now required for the eyes to become clinically cured and for conjunctival smears to fail to show gonococci.

A year ago, prompted by the encouraging reports1 appearing in medical literature on the use of sulfanilamide and sulfanilyldimethylsulfanilamide in the treatment of gonorrheal ophthalmia, we began giving sulfanilamide, in addition to the usual local treatment and foreign protein therapy, to our hospitalized patients with gonorrheal ophthalmia. The . . . [Full Text PDF of this Article]


Author Affiliations

SHANGHAI, CHINA

From the Ophthalmology Department of St. Luke's Hospital No. 2.


Footnotes

Read at the combined clinical conferences of St. Luke's hospitals No. 1 and No. 2 and of St. Elizabeth hospitals on Dec. 19, 1940.

The compound used was sulfanilyldimethylsulfanilamide. This is the most widely used drug in Germany for the treatment of gonorrhea. There is as yet no definite clinical evidence that it possesses any advantage over sulfanilamide or sulfapyridine in the treatment of this disease.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1941 American Medical Association. All Rights Reserved.